Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Levine MD, Wang H, Sriram B, Khan A, Senter L, McLaughlin EM, Bixel KL, Chambers LM, Cohn DE, Copeland LJ, Cosgrove CM, Nagel CI, O'Malley DM, Backes FJ. Levine MD, et al. Among authors: copeland lj. Gynecol Oncol. 2024 Mar;182:51-56. doi: 10.1016/j.ygyno.2023.12.008. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262238
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
Levine MD, Barrington DA, Meade CE, Lammers SM, McLaughlin EM, Suarez AA, Backes FJ, Copeland LJ, O'Malley DM, Cosgrove CM, Cohn DE, Nagel CI, Felix AS, Bixel KL. Levine MD, et al. Among authors: copeland lj. Gynecol Oncol. 2023 Jun;173:15-21. doi: 10.1016/j.ygyno.2023.03.023. Epub 2023 Apr 8. Gynecol Oncol. 2023. PMID: 37037083
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?
Levine MD, O'Malley DM, Haight PJ, Senter L, Wagner V, Bixel KL, Cohn DE, Copeland LJ, Cosgrove CM, McLaughlin EM, Backes FJ. Levine MD, et al. Among authors: copeland lj. Gynecol Oncol Rep. 2023 Mar 31;46:101173. doi: 10.1016/j.gore.2023.101173. eCollection 2023 Apr. Gynecol Oncol Rep. 2023. PMID: 37082521 Free PMC article.
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Morton M, McLaughlin EM, Calo CA, Lightfoot M, Bixel KL, Cohn DE, Cosgrove CM, Copeland LJ, O'Malley DM, Nagel CI, Chambers LM. Morton M, et al. Among authors: copeland lj. Gynecol Oncol. 2023 Oct;177:46-52. doi: 10.1016/j.ygyno.2023.08.009. Epub 2023 Aug 26. Gynecol Oncol. 2023. PMID: 37639902
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Haight PJ, Kistenfeger Q, Riedinger CJ, Khadraoui W, Backes FJ, Bixel KL, Copeland LJ, Cohn DE, Cosgrove CM, O'Malley DM, Nagel CI, Spakowicz DJ, Chambers LM. Haight PJ, et al. Among authors: copeland lj. Gynecol Oncol. 2023 Nov;178:14-22. doi: 10.1016/j.ygyno.2023.09.005. Epub 2023 Sep 21. Gynecol Oncol. 2023. PMID: 37741201
Wound complications following vulvar excision for nonmalignant lesions.
Boyles GP, Weaver AM, Cohn DE, Backes FJ, Copeland LJ, Bixel KL, Fowler JM, O'Malley DM, Cosgrove CM. Boyles GP, et al. Among authors: copeland lj. AJOG Glob Rep. 2021 Oct 6;1(4):100022. doi: 10.1016/j.xagr.2021.100022. eCollection 2021 Nov. AJOG Glob Rep. 2021. PMID: 36277453 Free PMC article.
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).
Pothuri B, Blank SV, Myers TK, Hines JF, Randall LM, O'Cearbhaill RE, Slomovitz BM, Eskander RN, Alvarez Secord A, Coleman RL, Walker JL, Monk BJ, Moore KN, O'Malley DM, Copeland LJ, Herzog TJ. Pothuri B, et al. Among authors: copeland lj. Gynecol Oncol. 2023 Jul;174:278-287. doi: 10.1016/j.ygyno.2023.05.006. Epub 2023 Jun 12. Gynecol Oncol. 2023. PMID: 37315373 No abstract available.
197 results